SCHEMBL6489245

SCHEMBL6489245

N#CC(C#N)=Cc1cccc(Br)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
KMT2A Q03164 7/20 0.54
ALDH1A1 P00352 7/20 0.54
MEN1 O00255 6/20 0.54
KDM4E B2RXH2 5/20 0.54
LMNA P02545 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
POLB P06746 2/20 0.54
EGFR P00533 6/20 0.52
TP53 P04637 3/20 0.52
CYP3A4 P08684 3/20 0.52
HPGD P15428 3/20 0.52
TSHR P16473 3/20 0.52
NFKB1 P19838 3/20 0.52
BLM P54132 3/20 0.52
PMP22 Q01453 3/20 0.52
MAPK1 P28482 2/20 0.52
CYP2C9 P11712 2/20 0.52
ALOX15 P16050 2/20 0.52
ALOX12 P18054 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865768 0.86 ALDH1A1 (0.65) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL13485335 0.80 MAPT (0.57) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL11556894 0.79 ALDH1A1 (0.52) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL11556898 0.79 ALDH1A1 (0.52) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL8543873 0.78 EGFR (0.64) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL14970320 0.78 MAPT (0.62) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL17466928 0.77 ALDH1A1 (0.54) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL30457529 0.77 KMT2A (0.56) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL30729660 0.77 MAPT (0.54) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL3368556 0.77 KMT2A (0.54) MAPTKMT2AALDH1A1MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232453-B 2- ((benzotriazolyl) (3-bromophenyl) methylene) malononitrile and preparation method thereof 天津师范大学 2021-07-20 CN claimed
CN-109232453-A 2- ((benzotriazole base) (3- bromophenyl) methylene) malononitrile and preparation method thereof 天津师范大学 2019-01-18 CN claimed
EP-3553097-B1 COPOLYMER AND OPTICAL FILM USING SAME TOSOH CORP (JP) 2022-05-04 EP disclosed
US-11225540-B2 Copolymer and optical film using same TOSOH CORPORATION (JP) 2022-01-18 US disclosed
CN-110092734-B Tandem synthesis method of 2- (phenylmethylene) malononitrile or derivatives thereof 华侨大学 2021-12-31 CN disclosed
CN-109232453-B 2- ((benzotriazolyl) (3-bromophenyl) methylene) malononitrile and preparation method thereof 天津师范大学 2021-07-20 CN disclosed
CN-109232453-B 2- ((benzotriazolyl) (3-bromophenyl) methylene) malononitrile and preparation method thereof 天津师范大学 2021-07-20 CN disclosed
US-20200095358-A1 COPOLYMER AND OPTICAL FILM USING SAME TOSOH CORPORATION (JP) 2020-03-26 US disclosed
CN-110818592-A Tandem reaction synthesis method of 2- (phenylmethylene) malononitrile or derivatives thereof 华侨大学 2020-02-21 CN disclosed
EP-3553097-A1 COPOLYMER AND OPTICAL FILM USING SAME Tosoh Corporation (JP) 2019-10-16 EP disclosed
CN-109232453-A 2- ((benzotriazole base) (3- bromophenyl) methylene) malononitrile and preparation method thereof 天津师范大学 2019-01-18 CN disclosed
WO-2000023444-A1 5,7-DISUBSTITUTED-4-AMINOPYRIDO[2,3-D]PYRIMIDINE COMPOUNDS ABBOTT LABORATORIES (US) 2000-04-27 WO disclosed
EP-0989986-A1 5,7-DISUBSTITUTED 4-AMINOPYRIDO 2,3-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS ADENOSINE KINASE INHIBITORS Abbott Laboratories (US) 2000-04-05 EP disclosed
WO-1999050254-A1 QUINOXALINONES AS SERINE PROTEASE INHIBITORS SUCH AS FACTOR XA AND THROMBIN WARNER-LAMBERT COMPANY (US) 1999-10-07 WO disclosed
WO-1999050257-A1 BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1999-10-07 WO disclosed
WO-1998046605-A1 5,7-DISUBSTITUTED 4-AMINOPYRIDO[2,3-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS ADENOSINE KINASE INHIBITORS ABBOTT LABORATORIES (US) 1998-10-22 WO disclosed
EP-0537949-B1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran LILLY CO ELI (GB) 1998-07-01 EP disclosed
US-5284868-A Naphthopyran derivatives; for autoimmune diseases, cancer ELI LILLY AND COMPANY (US) 1994-02-08 US disclosed
US-5281619-A Administering naphtho(1,2-B)pyran derivatives ELI LILLY AND COMPANY (US) 1994-01-25 US disclosed
EP-0537949-A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran LILLY INDUSTRIES LIMITED (GB) 1993-04-21 EP disclosed